506 related articles for article (PubMed ID: 34786893)
1. COVID 19 vaccine in patients of hypercoagulable disorders: a clinical perspective.
John NA; John J; Kamble P; Singhal A; Daulatabad V; Vamshidhar IS
Horm Mol Biol Clin Investig; 2021 Nov; 43(1):89-96. PubMed ID: 34786893
[TBL] [Abstract][Full Text] [Related]
2. COVID-19, thromboembolic risk, and Virchow's triad: Lesson from the past.
Mehta JL; Calcaterra G; Bassareo PP
Clin Cardiol; 2020 Dec; 43(12):1362-1367. PubMed ID: 33176009
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 as the cause of thrombosis: recognising COVID-19 infection in apparently asymptomatic patients.
Varner KB; Cox EJ
BMJ Case Rep; 2021 Jan; 14(1):. PubMed ID: 33414129
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 Associated Micro-Anastomotic Thrombosis After Abdominal Free Tissue Transfer: A Case Report and Literature Review.
Vonu P; Safeek R; Dadireddy K; Zumberg M; Spiguel L; Sorice-Virk S
Plast Surg (Oakv); 2023 Nov; 31(4):408-412. PubMed ID: 37908324
[TBL] [Abstract][Full Text] [Related]
5. Stress-Induced Hypercoagulability: Insights from Epidemiological and Mechanistic Studies, and Clinical Integration.
von Känel R
Semin Thromb Hemost; 2024 Jun; ():. PubMed ID: 38914118
[TBL] [Abstract][Full Text] [Related]
6. COVID-19 Thrombosis: Bridging the Old and New Concepts.
Gupta R; Choudhari OK; Mishra H; Ojha UC
Malays J Med Sci; 2021 Feb; 28(1):9-14. PubMed ID: 33679215
[TBL] [Abstract][Full Text] [Related]
7. Harmonizing hypercoagulable heterogeneity: Baseline VTE risk in COVID-19.
Goshua G; Lee AI
Res Pract Thromb Haemost; 2021 Jan; 5(1):9-10. PubMed ID: 33537523
[No Abstract] [Full Text] [Related]
8. Thrombosis management in times of COVID-19 epidemy; a Dutch perspective.
Ten Cate H
Thromb J; 2020; 18():7. PubMed ID: 32336956
[No Abstract] [Full Text] [Related]
9. Hypercoagulable State.
Beyan C
Med J Armed Forces India; 2006 Jul; 62(3):306. PubMed ID: 27407921
[No Abstract] [Full Text] [Related]
10. Miller Fisher syndrome following BNT162b2 mRNA coronavirus 2019 vaccination.
Nishiguchi Y; Matsuyama H; Maeda K; Shindo A; Tomimoto H
BMC Neurol; 2021 Nov; 21(1):452. PubMed ID: 34789193
[TBL] [Abstract][Full Text] [Related]
11. Optimization of non-coding regions for a non-modified mRNA COVID-19 vaccine.
Gebre MS; Rauch S; Roth N; Yu J; Chandrashekar A; Mercado NB; He X; Liu J; McMahan K; Martinot A; Martinez DR; Giffin V; Hope D; Patel S; Sellers D; Sanborn O; Barrett J; Liu X; Cole AC; Pessaint L; Valentin D; Flinchbaugh Z; Yalley-Ogunro J; Muench J; Brown R; Cook A; Teow E; Andersen H; Lewis MG; Boon ACM; Baric RS; Mueller SO; Petsch B; Barouch DH
Nature; 2022 Jan; 601(7893):410-414. PubMed ID: 34794169
[TBL] [Abstract][Full Text] [Related]
12. Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA.
Omer SB; Benjamin RM; Brewer NT; Buttenheim AM; Callaghan T; Caplan A; Carpiano RM; Clinton C; DiResta R; Elharake JA; Flowers LC; Galvani AP; Lakshmanan R; Maldonado YA; McFadden SM; Mello MM; Opel DJ; Reiss DR; Salmon DA; Schwartz JL; Sharfstein JM; Hotez PJ
Lancet; 2021 Dec; 398(10317):2186-2192. PubMed ID: 34793741
[TBL] [Abstract][Full Text] [Related]
13. Thrombotic events and COVID-19 vaccines.
Brazete C; Aguiar A; Furtado I; Duarte R
Int J Tuberc Lung Dis; 2021 Sep; 25(9):701-707. PubMed ID: 34802491
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the United States COVID-19 vaccine allocation strategy.
Islam MR; Oraby T; McCombs A; Chowdhury MM; Al-Mamun M; Tyshenko MG; Kadelka C
PLoS One; 2021; 16(11):e0259700. PubMed ID: 34788345
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of Anti-SARS-CoV-2 Vaccines in Common Variable Immunodeficiency.
Arroyo-Sánchez D; Cabrera-Marante O; Laguna-Goya R; Almendro-Vázquez P; Carretero O; Gil-Etayo FJ; Suàrez-Fernández P; Pérez-Romero P; Rodríguez de Frías E; Serrano A; Allende LM; Pleguezuelo D; Paz-Artal E
J Clin Immunol; 2022 Feb; 42(2):240-252. PubMed ID: 34787773
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing acceptance of the COVID-19 vaccine in Malaysia: a web-based survey.
Lau JFW; Woon YL; Leong CT; Teh HS
Osong Public Health Res Perspect; 2021 Dec; 12(6):361-373. PubMed ID: 34818501
[TBL] [Abstract][Full Text] [Related]
17. Thrombosis and thrombocytopenia after HPV vaccination.
Johansen S; Laegreid IJ; Ernstsen SL; Azrakhsh NA; Kittang AO; Lindås R; Gjertsen BT; Vetti N; Mørtberg TV; Sørvoll IH; Holme PA; Ahlen MT; Reikvam H
J Thromb Haemost; 2022 Mar; 20(3):700-704. PubMed ID: 34817130
[TBL] [Abstract][Full Text] [Related]
18. Myocardial Infarction, Stroke, and Pulmonary Embolism After BNT162b2 mRNA COVID-19 Vaccine in People Aged 75 Years or Older.
Jabagi MJ; Botton J; Bertrand M; Weill A; Farrington P; Zureik M; Dray-Spira R
JAMA; 2022 Jan; 327(1):80-82. PubMed ID: 34807248
[TBL] [Abstract][Full Text] [Related]
19. Heterogeneity of Vaccine-Induced Immune Thrombotic Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination and Safety of Second Vaccination with BNT162b2.
Lindhoff-Last E; Schoenborn L; Piorkowski M; Herold J; Greinacher A; Sheppard JA; Warkentin TE
Thromb Haemost; 2022 Feb; 122(2):304-307. PubMed ID: 34794199
[No Abstract] [Full Text] [Related]
20. An unusual presentation of acute deep vein thrombosis after the Moderna COVID-19 vaccine-a case report.
Bhan C; Bheesham N; Shakuntulla F; Sharma M; Sun C; Weinstein M
Ann Transl Med; 2021 Oct; 9(20):1605. PubMed ID: 34790811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
